Patent Results

7 Results for: citation_id:22235099
Make Note

Novel Ntrk1 Fusion Molecules And Uses Thereof

Methods Of Treating Cancers Characterized By Aberrent Ros1 Activity

Novel Chemical Compounds (variants) And The Use Thereof To Treat Oncological Diseases

  • Published: Apr 2, 2015
  • Family: 17
  • Cited scholarly works: 24
  • Cited by: 1
  • Cites: 10
  • Additional Info: Cited Works Full text Published
  • Applicant: Ltd Liability Company Nat Pharmaceutical Technologies

Methods Of Using Alk Inhibitors

Method Of Treating Cancer

  • Published: Dec 20, 2016
  • Family: 2
  • Cited scholarly works: 25
  • Cited by: 0
  • Cites: 0
  • Additional Info: Cited Works Full text
  • Owner: Macau University Of Science And Technology
  • Applicant: Univ Macau Sci & Tech

Mdm2 Inhibitors And Combinations Thereof

  • Published: Mar 9, 2017
  • Family: 4
  • Cited scholarly works: 39
  • Cited by: 0
  • Cites: 14
  • Additional Info: Cited Works Full text
  • Applicant: Novartis Ag, Halilovic Ensar, Caponigro Giordano, Horn-spirohn Thomas, Lehar Joseph

Chemical Compounds (derivatives) And Their Application For The Treatment Of Oncological Diseases

  • Published: Jul 4, 2017
  • Family: 17
  • Cited scholarly works: 29
  • Cited by: 0
  • Cites: 12
  • Additional Info: Cited Works Full text
  • Owner: Limited Liability Company "national Pharmaceutical Technologies", Limited Liability Company "pharmenterprises"
  • Applicant: Ltd Liability Company “national Pharmaceutical Technologies”, Ltd Liability Company “pharmenterprises”

Add Note

Sorry, you can't add a note to multiple items. You can add a note to your search as a saved query. Did you want to save this search and add a note to it?

Cancel Save Query

Sign in to the Lens